Appili Therapeutics Inc (TO:APLI) — Stock Price
Appili Therapeutics Inc (TO:APLI) is currently trading at CA$0.01 CAD, up 0.00% today. Over the past 52 weeks, shares have ranged between CA$0.01 and CA$0.04. This page tracks Appili Therapeutics Inc's live share price on the TO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Appili Therapeutics Inc worth.
Appili Therapeutics Inc (APLI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Appili Therapeutics Inc's daily closing share price and trading volume on the TO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Appili Therapeutics Inc Income Statement — Revenue, Profit & Earnings by Year
Appili Therapeutics Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CA$100.44K | CA$827.41K | CA$334.18K | CA$1.39 Million | CA$199.11K |
| Cost of Revenue | — | CA$13.66K | CA$6.27K | — | CA$14.84K |
| Gross Profit | CA$100.44K | CA$827.41K | CA$327.91K | CA$1.39 Million | CA$-14.84K |
| Research & Development | CA$7.33 Million | CA$5.62 Million | CA$3.81 Million | CA$21.46 Million | CA$11.49 Million |
| SG&A | CA$2.85 Million | CA$3.05 Million | CA$4.44 Million | CA$4.61 Million | CA$4.79 Million |
| Total Operating Expenses | CA$291.28K | CA$2.92 Million | CA$8.11 Million | CA$24.95 Million | CA$16.28 Million |
| Operating Income | CA$-190.84K | CA$-2.16 Million | CA$-7.91 Million | CA$-24.68 Million | CA$-16.30 Million |
| EBITDA | CA$360.57K | CA$-2.07 Million | CA$-8.10 Million | CA$-23.51 Million | CA$-14.87 Million |
| EBIT | CA$347.11K | CA$-2.08 Million | CA$-8.11 Million | CA$-23.52 Million | CA$-14.88 Million |
| Interest Expense | CA$3.50 Million | CA$1.63 Million | CA$1.10 Million | CA$1.55 Million | CA$69.84K |
| Income Before Tax | CA$-2.61 Million | CA$-3.71 Million | CA$-9.21 Million | CA$-25.08 Million | CA$-14.95 Million |
| Income Tax Expense | CA$18.83K | CA$69.58K | CA$36.39K | CA$38.46K | CA$-627.89K |
| Net Income | CA$-2.62 Million | CA$-3.78 Million | CA$-9.24 Million | CA$-25.12 Million | CA$-14.33 Million |
Appili Therapeutics Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Appili Therapeutics Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CA$3.03 Million | CA$1.49 Million | CA$3.13 Million | CA$8.28 Million | CA$18.32 Million |
| Total Current Assets | CA$3.01 Million | CA$1.46 Million | CA$3.12 Million | CA$8.24 Million | CA$18.26 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | CA$0.00 | CA$5.06 Million |
| Net Receivables | CA$1.67 Million | CA$1.17 Million | CA$420.78K | CA$1.39 Million | CA$1.69 Million |
| Inventory | — | — | — | — | CA$0.00 |
| Property, Plant & Equipment | CA$19.04K | CA$30.14K | CA$14.61K | CA$42.25K | CA$54.99K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CA$16.43 Million | CA$12.42 Million | CA$10.53 Million | CA$11.55 Million | CA$5.56 Million |
| Total Current Liabilities | CA$15.69 Million | CA$11.54 Million | CA$2.98 Million | CA$6.67 Million | CA$4.62 Million |
| Long-term Debt | CA$736.10K | CA$875.20K | CA$7.55 Million | CA$4.88 Million | CA$947.30K |
| Net Debt | CA$11.07 Million | CA$8.09 Million | CA$5.20 Million | CA$-1.69 Million | CA$-10.03 Million |
| Total Stockholder Equity | CA$-13.40 Million | CA$-10.92 Million | CA$-7.40 Million | CA$-3.27 Million | CA$12.75 Million |
| Retained Earnings | CA$-71.72 Million | CA$-69.09 Million | CA$-65.31 Million | CA$-56.07 Million | CA$-30.95 Million |
Appili Therapeutics Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Appili Therapeutics Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$868.82K | CA$-2.46 Million | CA$-10.10 Million | CA$-19.08 Million | CA$-11.45 Million |
| Capital Expenditures | CA$2.36K | CA$29.72K | CA$3.17K | CA$2.09K | CA$8.45K |
| Free Cash Flow | CA$866.46K | CA$-2.49 Million | CA$-10.10 Million | CA$-19.08 Million | CA$-11.46 Million |
| Investing Cash Flow | CA$-2.36K | CA$-29.06K | CA$-3.17K | CA$5.06 Million | CA$-4.99 Million |
| Financing Cash Flow | CA$193.68K | CA$122.05K | CA$5.91 Million | CA$9.56 Million | CA$17.02 Million |
| Dividends Paid | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 | CA$0.00 |
| Stock-Based Compensation | CA$117.80K | CA$191.34K | CA$875.12K | CA$2.04 Million | CA$1.17 Million |
| Depreciation | CA$13.46K | CA$13.66K | CA$6.27K | CA$12.64K | CA$14.84K |
| Change in Cash | CA$1.13 Million | CA$-2.37 Million | CA$-4.20 Million | CA$-4.40 Million | CA$553.31K |
Appili Therapeutics Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Appili Therapeutics Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 24, 2026 | — | — | — |
| Feb 19, 2026 | -0.01 | — | — |
| Nov 20, 2025 | -0.01 | — | — |
| Aug 19, 2025 | -0.01 | — | — |
| Jun 23, 2025 | 0.00 | — | — |
| Feb 14, 2025 | 0.00 | — | — |
| Nov 14, 2024 | -0.01 | — | — |
| Aug 13, 2024 | -0.01 | — | — |